Clinical Trial Update: Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial of fenretinide in patients with refractory or relapsed hematologic cancers has been completed, investigating safety across myeloproliferative ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myeloproliferative Neoplasms

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: California Cancer Consortium | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: COMPLETED